Concordant with accruing evidence, our finding highlights the essential role of BCL6 in the survival of DLBCL regardless of COO, and perhaps explains why targeting BCL6 is equally efficacious for suppression of both the very aggressive non-GCB and relatively less aggressive GCB type DHL [28]. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.